Disclaimer I am long $CVM to the tune of X0,000 shares (and growing). I genuinely believe, as a scientist, biochemist, and analyst, in Cel-Sci Corporation's Multikine. This article serves as the thesis that $CVM deserves that I have given to other stocks. As always buy shares, options are dangerous and are often used to manipulate the stock. Now that we have...
Disclaimer General disclaimer here. Short but sweet, we have sustained breakout from the bear pennant, we have a dwindling short pool (460k as of today borrowable from Fidelity, down from ~600k on Monday). Less kick in the shorts, and they have until the 20th of this month to sustain the price channel and try to get it under 7.5. Meanwhile, more and more...
Disclaimer Not financial advice, blah blah blah. Looking towards the end of current pennant into a gamma squeeze... Options for 8/20 look like a massive gamma at 10 possible, with another big jump at 12.5 and 15. We could see a massive impulse up with intense gamma pressure from ~1.2 million shares in calls at 10, and another ~700-800k between now and 20. All...
Disclaimer Not financial advice, I literally wrote that gold is worthless if everyone just decides it to be so. However, I put some effort into showing what I see what I look at the action. Everything is in the picture. TradingView fix your shit so I could have done this better. Never think the shorts have to cover, Freddie Mac and Fannie Mae are proof of...
DISCLAIMER I am financially invested in this stock, I have 4200 shares, and a considerable amount of calls for an unspecified date and amount. So yes, I, in a very big way, am selling you. I financially benefit if you, the investigative reader, buy CVM shares or, very possibly, calls. That means that this is not financial advice, this is a sales pitch, so if you...
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases.
Can Hedge Funds stop $GME from hitting $612?
Check out my previous analysis on TLRY, same idea. More legalization talks around cannabis this year with Democratic majorities in the U.S government. Potential buyout here as well.
Another stock that looks like a great time to buy in right now.
I have out lined the following TP: 50.00 SL: Below local HTF support. Pfizer sitting on fib support follow news of corona virus vaccine. It is reasonable to assume a break of ATH's in the future. Pays a good dividend in addition to the projected upside.
Why get subbed to to me on Tradingview? -TOP author on TradingView -15+ years experience in markets -Professional chart break downs -Supply/Demand Zones -TD9 counts / combo review -Key S/R levels -No junk on my charts -Frequent updates -Covering FX/crypto/US stocks -24/7 uptime so constant updates CVM 4D:: Best level to BUY // 100%+ SWING trade...
CLDR COOLING OFF AFTER RUMOURS OF A BUYOUT. COMPANY IS MEETING WITH PE FIRMS DISCUSSING M&A POSSIBILITIES. BREAKING OUT OF FALLING WEDGE 30% UPSIDE.
Weekly Chart : AMEX:CVM Finished the Major Down Trend on April 2019, and from then is in a solid Secondary Up Trend. Note 13.50 Historical level, which serve us as a good support to form a trade. Daily Chart : Minor Down Trend about to end (Yellow): Line Chart : The Trade Plan : Wait for a Clear Bullish Minor sign - 1....
Take profit 1: 7.50 Take profit 2: 10.00 FDA decision on the companies product Twirla. Womans contraceptive patch BRUDAC ADcomm voted 14-1 in favor. 200mmil marketcap with a 4bill addressable market. Chasing approval since 2013. Approval IS NOT for certain. They could be issued a CRL. Could go much higher on approval. Manage your risk accordingly.
Stock is making higher lows, finding resistance at the $9 level. Awaiting data for Phase 3 trial. killcvmshorts.com for more information. HIGH reward. All or nothing. Looking good for a long setup.
ITCI up 20% on the week and further 30% upside ahead! Looking to test 2019 resistance area around 14.50 ahead of its scheduled PDUFA approval on Dec.27th. TP 2 16.50.
This company is currently in Phase 3 of a pre treatment autoimmune therapy drug multikine that is aiming to improve your chances of chemo therapy by 10%. Results are expected within the next 6-12 months. And it could really hit a home run on the back of Phase 3 results. In the short term I expect investors to start taking bets and a test of the 10 level once...